SCHEMBL30813701

SCHEMBL30813701

COc1ccc(CNc2ncnc3c2c(B2OC(C)(C)C(C)(C)O2)cn3CCC(=O)OC(C)(C)C)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 17/20 0.38
▸ CYP3A4 P08684 17/20 0.38
▸ CYP2C19 P33261 17/20 0.38
▸ CYP2D6 P10635 15/20 0.38
▸ ALDH1A1 P00352 12/20 0.38
▸ TSHR P16473 12/20 0.38
▸ CLK4 Q9HAZ1 9/20 0.38
▸ HSD17B10 Q99714 9/20 0.38
▸ CYP2C9 P11712 9/20 0.38
▸ MAPK1 P28482 7/20 0.38
▸ USP2 O75604 7/20 0.38
▸ LMNA P02545 7/20 0.38
▸ ALOX15 P16050 4/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ MAPT P10636 2/20 0.37
▸ HIF1A Q16665 5/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27217966 1.00 CYP1A2 (0.38) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL27217755 0.83 CYP1A2 (0.45) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL30813518 0.83 CYP1A2 (0.45) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL27217956 0.81 SRC (0.45) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL30813462 0.81 SRC (0.45) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL30813471 0.79 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL27217965 0.79 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL20016696 0.78 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL19320359 0.76 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL30813583 0.73 USP30 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059200-A1 NEK7 INHIBITORS Halia Therapeutics, Inc. (US) 2024-03-21 — — WO disclosed
Send feedback